APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Docking and Virtual Screening Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Molecular Docking and Virtual Screening Software Market Outlook and Growth Opportunities 2026

12 August 2026192 pages

Choose your research edition.

Industry ResearchMolecular Docking and Virtual Screening Software Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Docking and Virtual Screening Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Molecular Docking and Virtual Screening Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Docking and Virtual Screening Software Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Docking and Virtual Screening Software Market Analysis and Forecast 2026-2032178 pages · $4,950 USD

Market perspective

The global Molecular Docking and Virtual Screening Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Molecular Docking and Virtual Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Molecular Docking and Virtual Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Molecular Docking and Virtual Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Molecular Docking and Virtual Screening Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Molecular Docking and Virtual Screening Software market include OpenEye Cadence Molecular Sciences, Cambridge Crystallographic Data Centre, Cresset, BioSolveIT, Molsoft, Molecular Discovery, DP Technology, XtalPi and Schrödinger, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Molecular Docking and Virtual Screening Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Molecular Docking and Virtual Screening Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molecular Docking and Virtual Screening Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Molecular Docking and Virtual Screening Software market.

Molecular Docking and Virtual Screening Software Segment by Company

OpenEye Cadence Molecular Sciences

Cambridge Crystallographic Data Centre

Cresset

BioSolveIT

Molsoft

Molecular Discovery

DP Technology

XtalPi

Schrödinger

Dassault Systèmes

Chemical Computing Group

Molecular Docking and Virtual Screening Software Segment by Type

Structure-Based Docking Software

Ligand-Based Screening Software

Pharmacophore Screening Software

Shape and Electrostatic Similarity Software

AI-Assisted Docking Software

Molecular Docking and Virtual Screening Software Segment by Application

Hit Discovery

Lead Optimization

Drug Repurposing

Fragment-Based Drug Design

Target Validation and Mechanism Study

Teaching and Academic Research

Molecular Docking and Virtual Screening Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Molecular Docking and Virtual Screening Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Molecular Docking and Virtual Screening Software key companies, revenue, market share, and recent developments.

3. To split the Molecular Docking and Virtual Screening Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Molecular Docking and Virtual Screening Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Molecular Docking and Virtual Screening Software significant trends, drivers, influence factors in global and regions.

6. To analyze Molecular Docking and Virtual Screening Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Docking and Virtual Screening Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Docking and Virtual Screening Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Docking and Virtual Screening Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Molecular Docking and Virtual Screening Software industry.

Chapter 3: Detailed analysis of Molecular Docking and Virtual Screening Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Molecular Docking and Virtual Screening Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Molecular Docking and Virtual Screening Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Molecular Docking and Virtual Screening Software Industry Trends Table 2. Molecular Docking and Virtual Screening Software Industry Drivers Table 3. Molecular Docking and Virtual Screening Software Industry Opportunities and Challenges Table 4. Molecular Docking and Virtual Screening Software Industry Restraints Table 5. Global Molecular Docking and Virtual Screening Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Molecular Docking and Virtual Screening Software Revenue Share by Company (2021-2026) Table 7. Global Molecular Docking and Virtual Screening Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Molecular Docking and Virtual Screening Software Key Company Manufacturing Base & Headquarters Table 9. Global Molecular Docking and Virtual Screening Software Company, Product Type & Application Table 10. Global Molecular Docking and Virtual Screening Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Molecular Docking and Virtual Screening Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Structure-Based Docking Software Table 15. Significant Companies of Ligand-Based Screening Software Table 16. Significant Companies of Pharmacophore Screening Software Table 17. Significant Companies of Shape and Electrostatic Similarity Software Table 18. Significant Companies of AI-Assisted Docking Software Table 19. Global Molecular Docking and Virtual Screening Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Molecular Docking and Virtual Screening Software Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Molecular Docking and Virtual Screening Software Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Molecular Docking and Virtual Screening Software Sales Value Share by Type (2021-2026) Table 23. Global Molecular Docking and Virtual Screening Software Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hit Discovery Table 25. Significant Companies of Lead Optimization Table 26. Significant Companies of Drug Repurposing Table 27. Significant Companies of Fragment-Based Drug Design Table 28. Significant Companies of Target Validation and Mechanism Study Table 29. Significant Companies of Teaching and Academic Research Table 30. Global Molecular Docking and Virtual Screening Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Molecular Docking and Virtual Screening Software Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global Molecular Docking and Virtual Screening Software Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global Molecular Docking and Virtual Screening Software Sales Value Share by Application (2021-2026) Table 34. Global Molecular Docking and Virtual Screening Software Sales Value Share by Application (2027-2032) Table 35. Global Molecular Docking and Virtual Screening Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Molecular Docking and Virtual Screening Software Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global Molecular Docking and Virtual Screening Software Sales Value Share by Region (2021-2026) Table 38. Global Molecular Docking and Virtual Screening Software Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global Molecular Docking and Virtual Screening Software Sales Value Share by Region (2027-2032) Table 40. Global Molecular Docking and Virtual Screening Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Molecular Docking and Virtual Screening Software Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global Molecular Docking and Virtual Screening Software Sales Value Market Share by Country (2021-2026) Table 43. Global Molecular Docking and Virtual Screening Software Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global Molecular Docking and Virtual Screening Software Sales Value Market Share by Country (2027-2032) Table 45. OpenEye Cadence Molecular Sciences Company Information Table 46. OpenEye Cadence Molecular Sciences Business Overview Table 47. OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Product Portfolio Table 49. OpenEye Cadence Molecular Sciences Recent Development Table 50. Cambridge Crystallographic Data Centre Company Information Table 51. Cambridge Crystallographic Data Centre Business Overview Table 52. Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Product Portfolio Table 54. Cambridge Crystallographic Data Centre Recent Development Table 55. Cresset Company Information Table 56. Cresset Business Overview Table 57. Cresset Molecular Docking and Virtual Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Cresset Molecular Docking and Virtual Screening Software Product Portfolio Table 59. Cresset Recent Development Table 60. BioSolveIT Company Information Table 61. BioSolveIT Business Overview Table 62. BioSolveIT Molecular Docking and Virtual Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. BioSolveIT Molecular Docking and Virtual Screening Software Product Portfolio Table 64. BioSolveIT Recent Development Table 65. Molsoft Company Information Table 66. Molsoft Business Overview Table 67. Molsoft Molecular Docking and Virtual Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Molsoft Molecular Docking and Virtual Screening Software Product Portfolio Table 69. Molsoft Recent Development Table 70. Molecular Discovery Company Information Table 71. Molecular Discovery Business Overview Table 72. Molecular Discovery Molecular Docking and Virtual Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Molecular Discovery Molecular Docking and Virtual Screening Software Product Portfolio Table 74. Molecular Discovery Recent Development Table 75. DP Technology Company Information Table 76. DP Technology Business Overview Table 77. DP Technology Molecular Docking and Virtual Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. DP Technology Molecular Docking and Virtual Screening Software Product Portfolio Table 79. DP Technology Recent Development Table 80. XtalPi Company Information Table 81. XtalPi Business Overview Table 82. XtalPi Molecular Docking and Virtual Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. XtalPi Molecular Docking and Virtual Screening Software Product Portfolio Table 84. XtalPi Recent Development Table 85. Schrödinger Company Information Table 86. Schrödinger Business Overview Table 87. Schrödinger Molecular Docking and Virtual Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Schrödinger Molecular Docking and Virtual Screening Software Product Portfolio Table 89. Schrödinger Recent Development Table 90. Dassault Systèmes Company Information Table 91. Dassault Systèmes Business Overview Table 92. Dassault Systèmes Molecular Docking and Virtual Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Dassault Systèmes Molecular Docking and Virtual Screening Software Product Portfolio Table 94. Dassault Systèmes Recent Development Table 95. Chemical Computing Group Company Information Table 96. Chemical Computing Group Business Overview Table 97. Chemical Computing Group Molecular Docking and Virtual Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Chemical Computing Group Molecular Docking and Virtual Screening Software Product Portfolio Table 99. Chemical Computing Group Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Molecular Docking and Virtual Screening Software Product Image Figure 2. Global Molecular Docking and Virtual Screening Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Docking and Virtual Screening Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Molecular Docking and Virtual Screening Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Structure-Based Docking Software Image Figure 8. Ligand-Based Screening Software Image Figure 9. Pharmacophore Screening Software Image Figure 10. Shape and Electrostatic Similarity Software Image Figure 11. AI-Assisted Docking Software Image Figure 12. Global Molecular Docking and Virtual Screening Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Molecular Docking and Virtual Screening Software Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Molecular Docking and Virtual Screening Software Sales Value Share by Type (2021-2032) Figure 15. Hit Discovery Image Figure 16. Lead Optimization Image Figure 17. Drug Repurposing Image Figure 18. Fragment-Based Drug Design Image Figure 19. Target Validation and Mechanism Study Image Figure 20. Teaching and Academic Research Image Figure 21. Global Molecular Docking and Virtual Screening Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Molecular Docking and Virtual Screening Software Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Molecular Docking and Virtual Screening Software Sales Value Share by Application (2021-2032) Figure 24. Global Molecular Docking and Virtual Screening Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global Molecular Docking and Virtual Screening Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America Molecular Docking and Virtual Screening Software Sales Value (2021-2032) & (US$ Million) Figure 27. North America Molecular Docking and Virtual Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe Molecular Docking and Virtual Screening Software Sales Value (2021-2032) & (US$ Million) Figure 29. Europe Molecular Docking and Virtual Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific Molecular Docking and Virtual Screening Software Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Molecular Docking and Virtual Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America Molecular Docking and Virtual Screening Software Sales Value (2021-2032) & (US$ Million) Figure 33. South America Molecular Docking and Virtual Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa Molecular Docking and Virtual Screening Software Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Molecular Docking and Virtual Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Structure-Based Docking Software
  • Ligand-Based Screening Software
  • Pharmacophore Screening Software
  • Shape and Electrostatic Similarity Software
  • AI-Assisted Docking Software
Applications
  • Hit Discovery
  • Lead Optimization
  • Drug Repurposing
  • Fragment-Based Drug Design
  • Target Validation and Mechanism Study
  • Teaching and Academic Research
Companies covered
  • OpenEye Cadence Molecular Sciences
  • Cambridge Crystallographic Data Centre
  • Cresset
  • BioSolveIT
  • Molsoft
  • Molecular Discovery
  • DP Technology
  • XtalPi
  • Schrödinger
  • Dassault Systèmes
  • Chemical Computing Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Molecular Docking and Virtual Screening Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Molecular Docking and Virtual Screening Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Molecular Docking and Virtual Screening Software Market Dynamics
  1. 2.1 Molecular Docking and Virtual Screening Software Industry Trends
  2. 2.2 Molecular Docking and Virtual Screening Software Industry Drivers
  3. 2.3 Molecular Docking and Virtual Screening Software Industry Opportunities and Challenges
  4. 2.4 Molecular Docking and Virtual Screening Software Industry Restraints
3 Molecular Docking and Virtual Screening Software Market by Company
  1. 3.1 Global Molecular Docking and Virtual Screening Software Company Revenue Ranking in 2025
  2. 3.2 Global Molecular Docking and Virtual Screening Software Revenue by Company (2021-2026)
  3. 3.3 Global Molecular Docking and Virtual Screening Software Company Ranking (2024-2026)
  4. 3.4 Global Molecular Docking and Virtual Screening Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Molecular Docking and Virtual Screening Software Company Product Type and Application
  6. 3.6 Global Molecular Docking and Virtual Screening Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Molecular Docking and Virtual Screening Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Molecular Docking and Virtual Screening Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Molecular Docking and Virtual Screening Software Market by Type
  1. 4.1 Molecular Docking and Virtual Screening Software Type Introduction
  2. 4.1.1 Structure-Based Docking Software
  3. 4.1.2 Ligand-Based Screening Software
  4. 4.1.3 Pharmacophore Screening Software
  5. 4.1.4 Shape and Electrostatic Similarity Software
  6. 4.1.5 AI-Assisted Docking Software
  7. 4.2 Global Molecular Docking and Virtual Screening Software Sales Value by Type
  8. 4.2.1 Global Molecular Docking and Virtual Screening Software Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Molecular Docking and Virtual Screening Software Sales Value by Type (2021-2032)
  10. 4.2.3 Global Molecular Docking and Virtual Screening Software Sales Value Share by Type (2021-2032)
5 Molecular Docking and Virtual Screening Software Market by Application
  1. 5.1 Molecular Docking and Virtual Screening Software Application Introduction
  2. 5.1.1 Hit Discovery
  3. 5.1.2 Lead Optimization
  4. 5.1.3 Drug Repurposing
  5. 5.1.4 Fragment-Based Drug Design
  6. 5.1.5 Target Validation and Mechanism Study
  7. 5.1.6 Teaching and Academic Research
  8. 5.2 Global Molecular Docking and Virtual Screening Software Sales Value by Application
  9. 5.2.1 Global Molecular Docking and Virtual Screening Software Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Molecular Docking and Virtual Screening Software Sales Value by Application (2021-2032)
  11. 5.2.3 Global Molecular Docking and Virtual Screening Software Sales Value Share by Application (2021-2032)
6 Molecular Docking and Virtual Screening Software Regional Value Analysis
  1. 6.1 Global Molecular Docking and Virtual Screening Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Molecular Docking and Virtual Screening Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Molecular Docking and Virtual Screening Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Molecular Docking and Virtual Screening Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Molecular Docking and Virtual Screening Software Sales Value (2021-2032)
  7. 6.3.2 North America Molecular Docking and Virtual Screening Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Molecular Docking and Virtual Screening Software Sales Value (2021-2032)
  10. 6.4.2 Europe Molecular Docking and Virtual Screening Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Molecular Docking and Virtual Screening Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Molecular Docking and Virtual Screening Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Molecular Docking and Virtual Screening Software Sales Value (2021-2032)
  16. 6.6.2 South America Molecular Docking and Virtual Screening Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Molecular Docking and Virtual Screening Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Molecular Docking and Virtual Screening Software Sales Value Share by Country, 2025 VS 2032
7 Molecular Docking and Virtual Screening Software Country-level Value Analysis
  1. 7.1 Global Molecular Docking and Virtual Screening Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Molecular Docking and Virtual Screening Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Molecular Docking and Virtual Screening Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Molecular Docking and Virtual Screening Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Molecular Docking and Virtual Screening Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Molecular Docking and Virtual Screening Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Molecular Docking and Virtual Screening Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 OpenEye Cadence Molecular Sciences
  2. 8.1.1 OpenEye Cadence Molecular Sciences Company Information
  3. 8.1.2 OpenEye Cadence Molecular Sciences Business Overview
  4. 8.1.3 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Product Portfolio
  6. 8.1.5 OpenEye Cadence Molecular Sciences Recent Developments
  7. 8.2 Cambridge Crystallographic Data Centre
  8. 8.2.1 Cambridge Crystallographic Data Centre Company Information
  9. 8.2.2 Cambridge Crystallographic Data Centre Business Overview
  10. 8.2.3 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Product Portfolio
  12. 8.2.5 Cambridge Crystallographic Data Centre Recent Developments
  13. 8.3 Cresset
  14. 8.3.1 Cresset Company Information
  15. 8.3.2 Cresset Business Overview
  16. 8.3.3 Cresset Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cresset Molecular Docking and Virtual Screening Software Product Portfolio
  18. 8.3.5 Cresset Recent Developments
  19. 8.4 BioSolveIT
  20. 8.4.1 BioSolveIT Company Information
  21. 8.4.2 BioSolveIT Business Overview
  22. 8.4.3 BioSolveIT Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BioSolveIT Molecular Docking and Virtual Screening Software Product Portfolio
  24. 8.4.5 BioSolveIT Recent Developments
  25. 8.5 Molsoft
  26. 8.5.1 Molsoft Company Information
  27. 8.5.2 Molsoft Business Overview
  28. 8.5.3 Molsoft Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Molsoft Molecular Docking and Virtual Screening Software Product Portfolio
  30. 8.5.5 Molsoft Recent Developments
  31. 8.6 Molecular Discovery
  32. 8.6.1 Molecular Discovery Company Information
  33. 8.6.2 Molecular Discovery Business Overview
  34. 8.6.3 Molecular Discovery Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Molecular Discovery Molecular Docking and Virtual Screening Software Product Portfolio
  36. 8.6.5 Molecular Discovery Recent Developments
  37. 8.7 DP Technology
  38. 8.7.1 DP Technology Company Information
  39. 8.7.2 DP Technology Business Overview
  40. 8.7.3 DP Technology Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 DP Technology Molecular Docking and Virtual Screening Software Product Portfolio
  42. 8.7.5 DP Technology Recent Developments
  43. 8.8 XtalPi
  44. 8.8.1 XtalPi Company Information
  45. 8.8.2 XtalPi Business Overview
  46. 8.8.3 XtalPi Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 XtalPi Molecular Docking and Virtual Screening Software Product Portfolio
  48. 8.8.5 XtalPi Recent Developments
  49. 8.9 Schrödinger
  50. 8.9.1 Schrödinger Company Information
  51. 8.9.2 Schrödinger Business Overview
  52. 8.9.3 Schrödinger Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Schrödinger Molecular Docking and Virtual Screening Software Product Portfolio
  54. 8.9.5 Schrödinger Recent Developments
  55. 8.10 Dassault Systèmes
  56. 8.10.1 Dassault Systèmes Company Information
  57. 8.10.2 Dassault Systèmes Business Overview
  58. 8.10.3 Dassault Systèmes Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dassault Systèmes Molecular Docking and Virtual Screening Software Product Portfolio
  60. 8.10.5 Dassault Systèmes Recent Developments
  61. 8.11 Chemical Computing Group
  62. 8.11.1 Chemical Computing Group Company Information
  63. 8.11.2 Chemical Computing Group Business Overview
  64. 8.11.3 Chemical Computing Group Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Chemical Computing Group Molecular Docking and Virtual Screening Software Product Portfolio
  66. 8.11.5 Chemical Computing Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst